| 注册
首页|期刊导航|中国伤残医学|CD117、CD13、CD33在鉴别诊断AML中的应用评价

CD117、CD13、CD33在鉴别诊断AML中的应用评价

郭冬芳

中国伤残医学Issue(6):43-44,2.
中国伤残医学Issue(6):43-44,2.

CD117、CD13、CD33在鉴别诊断AML中的应用评价

Differential Diagnosis Value of CD117, CD13 and CD33 in Acute Myeloid Leukemia

郭冬芳1

作者信息

  • 1. 驻马店市中心医院检验科,河南 驻马店 463000
  • 折叠

摘要

Abstract

Objectives:To study the differential diagnosis value of CD 117 、CD13 and CD33 in acute myeloid leukemia .Methods:The peripheral blood and bone marrow of 510 cases with acute myeloid leukemia was analyzed by flow cytometry .Results:In acute myeloid leu-kemia, the percent of expression in CD117,CD13 and CD33 was 91.9%、91.6%and 94.4%.These were significantly higher compared with acute lymphoblastic leukemia (P<0.01);Conclusion:CD117,CD13 and CD33 might be significant in differential diagnosis between acute myeloid leukemia and acute lymphoblastic leukemia .

关键词

急性髓细胞性白血病/急性淋巴细胞性白血病/CD13/CD33/CD117

Key words

Acute myeloid leukemia/Acute lymphoblastic leukemia/CD13、CD33 、CD117

分类

医药卫生

引用本文复制引用

郭冬芳..CD117、CD13、CD33在鉴别诊断AML中的应用评价[J].中国伤残医学,2014,(6):43-44,2.

中国伤残医学

1673-6567

访问量0
|
下载量0
段落导航相关论文